5x 1 year subscription
€535.00
Related products
-
Article: Highlights in urologic cancer
€2.50 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.50 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€2.50 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.50 Add to cart
